As of 2024-12-15, the Relative Valuation of HLS Therapeutics Inc (HLS.TO) is (18.45) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 3.64 CAD, the upside of HLS Therapeutics Inc based on Relative Valuation is -606.9%.
The range of the Relative Valuation is (18.92) - (19.16) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 21.8x | 21.2x |
| Forward P/E multiples | 12.1x - 19.4x | 16.2x |
| Fair Price | (18.92) - (19.16) | (18.45) |
| Upside | -619.9% - -626.4% | -606.9% |
| Date | P/E |
| 2024-12-10 | -4.92 |
| 2024-12-09 | -4.98 |
| 2024-12-06 | -4.91 |
| 2024-12-05 | -4.92 |
| 2024-12-04 | -5.06 |
| 2024-12-03 | -5.08 |
| 2024-12-02 | -5.14 |
| 2024-11-29 | -5.21 |
| 2024-11-28 | -5.12 |
| 2024-11-27 | -5.06 |
| 2024-11-26 | -5.12 |
| 2024-11-25 | -5.05 |
| 2024-11-22 | -4.93 |
| 2024-11-21 | -4.78 |
| 2024-11-20 | -4.52 |
| 2024-11-19 | -4.63 |
| 2024-11-18 | -4.56 |
| 2024-11-15 | -4.59 |
| 2024-11-14 | -4.69 |
| 2024-11-13 | -4.86 |
| 2024-11-12 | -4.99 |
| 2024-11-11 | -5.27 |
| 2024-11-08 | -5.27 |
| 2024-11-07 | -5.34 |
| 2024-11-06 | -4.91 |
| 2024-11-05 | -4.80 |
| 2024-11-04 | -4.76 |
| 2024-11-01 | -4.69 |
| 2024-10-31 | -4.82 |
| 2024-10-30 | -4.91 |
| 2024-10-29 | -5.01 |
| 2024-10-28 | -5.05 |
| 2024-10-25 | -5.06 |
| 2024-10-24 | -5.54 |
| 2024-10-23 | -5.58 |
| 2024-10-22 | -5.55 |
| 2024-10-21 | -5.57 |
| 2024-10-18 | -5.63 |
| 2024-10-17 | -5.70 |
| 2024-10-16 | -5.64 |
| 2024-10-15 | -5.76 |
| 2024-10-11 | -5.43 |
| 2024-10-10 | -5.34 |
| 2024-10-09 | -5.44 |
| 2024-10-08 | -5.68 |
| 2024-10-07 | -5.19 |
| 2024-10-04 | -5.27 |
| 2024-10-03 | -5.35 |
| 2024-10-02 | -5.35 |
| 2024-10-01 | -5.28 |